- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Senators Enquire on Policy for Biosimilars
Within a week of Sandoz applying for approval of it's biosimlar to Amgen's Neupogen, U.S. senators want the FDA to lay down guidelines on naming these drugs.
One week after the FDA received its first request to approve a biosimilar medicine, a handful of U.S. senators has asked the U.S. Department of Health and Human services when a formal policy will be adopted for naming these medications.
Their missive was sent just as the World Health Organization suggested a new proposal for naming biosimilars, which are designed to emulate brand-name biologics and are forecast to save billions of dollars in health care costs.
At issue is whether biosimilars should be given the same International Proprietary Name, or INN, as brand-name biologics. The WHO oversees the global INN system, but individual regulatory agencies in each country are not bound by the latest WHO proposal.
As we have noted previously, the naming debate is particularly contentious and has divided the pharmaceutical industry, which has been lobbying the FDA to chart a course. A central focus of the debate is whether different INNs would hamper substitution needed for lowering health care costs.
Original report: http://on.wsj.com/1tSZlAX
Source: The Wall Street Journal
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
June 12th 2025Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.
Read More
